Fedha

Hisa unazofuatilia
6MK:FRA
Merck & Co.
€ 131.16
-0.09%
(-0.12) Siku 1
14 Okt, 22:00:00 GMT +2  ·   EUR
Alama zote
AlamaBeiTofautiTofauti ya asilimia
Inatayarisha maarifa maarufu ya 6MK...
Fungua
€ 126.72
Juu
€ 131.16
Chini
€ 126.72
Mtaji wa soko
363.59B
Wastani wa kiasi cha mauzo
423.00
Kiasi cha mauzo ya hisa
582.00
Juu kwa wiki 52
€ 134.54
Chini kwa wiki 52
€ 71.00
Idadi ya wafanyakazi
elfu 74
Fungua
€ 126.72
Juu
€ 131.16
Chini
€ 126.72
Mtaji wa soko
363.59B
Wastani wa kiasi cha mauzo
423.00
Kiasi cha mauzo ya hisa
582.00
Juu kwa wiki 52
€ 134.54
Chini kwa wiki 52
€ 71.00
Idadi ya wafanyakazi
elfu 74
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
Wasifu
Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. The company is ranked fifth on the list of largest biomedical companies by revenue. The company's revenues are primarily from cancer treatments, vaccines, and animal health products. In 2024, 46% of the company's revenue, or $29.5 billion, came from sales of Keytruda, a PD-1 inhibitor used to treat various types of cancers, and 13% of the company's revenue, or $8.6 billion, came from sales of Gardasil, an HPV vaccine. In addition, 9% of the company's revenue, or $5.8 billion, came from the sales of animal health products. The company is ranked 65th on the Fortune 500 and 76th on the Forbes Global 2000. In 1891, Merck & Co. was established as the American affiliate of the Merck Group, founded by the Merck family, and the companies are still in trademark disputes in several countries over the right to use the name "Merck". Wikipedia
Kuhusu Merck & Co.
Afisa Mkuu Mtendaji (CEO)Robert M Davis
Wafanyakazielfu 74
Lilianzishwa1 Jan 1891
Makao makuu-
Sekta-
Tovutimerck.com
Ripoti za awaliThamani zote katika USD
Loading Previous Earnings...
Mapato
Mapato halisi
Thamani zote katika USD
Sep 2025
Des 2025
Mac 2026
Jun 2026
Mapato
17.28B
16.40B
16.29B
16.61B
Gharama ya bidhaa zilizouzwa
3.74B
4.30B
3.88B
4.13B
Gharama ya mapato
3.74B
4.30B
3.88B
4.13B
Gharama za utafiti na maendeleo
4.00B
4.00B
3.56B
9.74B
Jumla ya gharama za utafiti na maendeleo
-
-
-
-
Gharama za uuzaji, za jumla na za usimamizi
2.48B
2.73B
2.57B
2.78B
Gharama ya uendeshaji
6.48B
6.73B
6.12B
12.52B
Jumla ya gharama za uendeshaji
10.23B
11.02B
10.00B
16.65B
Mapato ya uendeshaji
7.05B
5.38B
6.29B
-40.00M
Mapato mengine yasiyo ya uendeshaji
-
41.00M
42.00M
59.00M
EBT ikijumuisha vipengee visivyo vya kawaida
6.74B
3.42B
-3.53B
-683.00M
EBT bila kujumuisha vipengee visivyo vya kawaida
6.76B
4.98B
5.85B
-508.00M
Gharama ya kodi ya mapato
958.00M
458.00M
709.00M
654.00M
Kiwango cha kodi kinachotumika
14.20%
13.39%
-20.06%
-95.75%
Gharama nyingine za uendeshaji
-
-
-
-
Mapato halisi
5.78B
2.96B
-4.24B
-1.34B
Kiwango cha faida halisi
33.49%
18.07%
-26.03%
-8.04%
Mapato kwa kila hisa
2.58
2.04
-1.28
-0.13
Mapato ya riba na uwekezaji
96.00M
69.00M
35.00M
35.00M
Gharama ya riba
-327.00M
-411.00M
-479.00M
-525.00M
Jumla ya gharama halisi za riba
-231.00M
-342.00M
-444.00M
-490.00M
Gharama za kushuka kwa thamani na za kulipa deni
-
-
-
-
Mapato ya kampuni kabla ya riba, kodi, kushuka thamani na kulipa madeni
8.15B
6.79B
7.69B
1.43B
Faida au hasara kutokana na uuzaji wa vipengee
-
-
-
-
Maudhui yaliyotayarishwa kwa AI yanaweza kuwa na makosa. Pata maelezo zaidi
Programu za Google